Evidence-based process for decision-making in the analysis of legal demands for medicines in Brazil

Detalhes bibliográficos
Autor(a) principal: Figueiredo,Tatiana Aragão
Data de Publicação: 2013
Outros Autores: Osorio-de-Castro,Claudia Garcia Serpa, Pepe,Vera Lúcia Edais
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Cadernos de Saúde Pública
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-311X2013001300014
Resumo: Legal actions have been playing a significant role as an alternative pathway to access to medicines in Brazil. These lawsuits demand medicines used in Primary Health Care as well as medicines that are still in clinical research and have not been market approved by the Brazilian National Agency for Sanitary Surveillance (ANVISA). The goal was to analyze medicines demanded through lawsuits brought to the judicial district which includes the city of Rio de Janeiro, Brazil, from July/2007 to June/2008. The medicines in 281 lawsuits were examined for their respective indications, classified according to their presence in publicly-funded lists, market approval by ANVISA, compliance with national clinical guidelines, existence of alternative therapies in lists and support of indication by scientific evidence. Six different categories were described, which are deemed useful to managers and the Judiciary in decision-making. The support of evidence is of utmost importance for medicines that are not included in public funding lists and also for those with no available therapeutic alternatives.
id FIOCRUZ-5_8c18c2b361ce60d4bf258937aef74463
oai_identifier_str oai:scielo:S0102-311X2013001300014
network_acronym_str FIOCRUZ-5
network_name_str Cadernos de Saúde Pública
repository_id_str
spelling Evidence-based process for decision-making in the analysis of legal demands for medicines in BrazilEvidence Based MedicinePharmaceutical ServicesRight to HealthHealth Technology EvaluationLegal actions have been playing a significant role as an alternative pathway to access to medicines in Brazil. These lawsuits demand medicines used in Primary Health Care as well as medicines that are still in clinical research and have not been market approved by the Brazilian National Agency for Sanitary Surveillance (ANVISA). The goal was to analyze medicines demanded through lawsuits brought to the judicial district which includes the city of Rio de Janeiro, Brazil, from July/2007 to June/2008. The medicines in 281 lawsuits were examined for their respective indications, classified according to their presence in publicly-funded lists, market approval by ANVISA, compliance with national clinical guidelines, existence of alternative therapies in lists and support of indication by scientific evidence. Six different categories were described, which are deemed useful to managers and the Judiciary in decision-making. The support of evidence is of utmost importance for medicines that are not included in public funding lists and also for those with no available therapeutic alternatives.Escola Nacional de Saúde Pública Sergio Arouca, Fundação Oswaldo Cruz2013-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-311X2013001300014Cadernos de Saúde Pública v.29 suppl.1 2013reponame:Cadernos de Saúde Públicainstname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZ10.1590/0102-311X00161812info:eu-repo/semantics/openAccessFigueiredo,Tatiana AragãoOsorio-de-Castro,Claudia Garcia SerpaPepe,Vera Lúcia Edaiseng2013-11-12T00:00:00Zoai:scielo:S0102-311X2013001300014Revistahttp://cadernos.ensp.fiocruz.br/csp/https://old.scielo.br/oai/scielo-oai.phpcadernos@ensp.fiocruz.br||cadernos@ensp.fiocruz.br1678-44640102-311Xopendoar:2013-11-12T00:00Cadernos de Saúde Pública - Fundação Oswaldo Cruz (FIOCRUZ)false
dc.title.none.fl_str_mv Evidence-based process for decision-making in the analysis of legal demands for medicines in Brazil
title Evidence-based process for decision-making in the analysis of legal demands for medicines in Brazil
spellingShingle Evidence-based process for decision-making in the analysis of legal demands for medicines in Brazil
Figueiredo,Tatiana Aragão
Evidence Based Medicine
Pharmaceutical Services
Right to Health
Health Technology Evaluation
title_short Evidence-based process for decision-making in the analysis of legal demands for medicines in Brazil
title_full Evidence-based process for decision-making in the analysis of legal demands for medicines in Brazil
title_fullStr Evidence-based process for decision-making in the analysis of legal demands for medicines in Brazil
title_full_unstemmed Evidence-based process for decision-making in the analysis of legal demands for medicines in Brazil
title_sort Evidence-based process for decision-making in the analysis of legal demands for medicines in Brazil
author Figueiredo,Tatiana Aragão
author_facet Figueiredo,Tatiana Aragão
Osorio-de-Castro,Claudia Garcia Serpa
Pepe,Vera Lúcia Edais
author_role author
author2 Osorio-de-Castro,Claudia Garcia Serpa
Pepe,Vera Lúcia Edais
author2_role author
author
dc.contributor.author.fl_str_mv Figueiredo,Tatiana Aragão
Osorio-de-Castro,Claudia Garcia Serpa
Pepe,Vera Lúcia Edais
dc.subject.por.fl_str_mv Evidence Based Medicine
Pharmaceutical Services
Right to Health
Health Technology Evaluation
topic Evidence Based Medicine
Pharmaceutical Services
Right to Health
Health Technology Evaluation
description Legal actions have been playing a significant role as an alternative pathway to access to medicines in Brazil. These lawsuits demand medicines used in Primary Health Care as well as medicines that are still in clinical research and have not been market approved by the Brazilian National Agency for Sanitary Surveillance (ANVISA). The goal was to analyze medicines demanded through lawsuits brought to the judicial district which includes the city of Rio de Janeiro, Brazil, from July/2007 to June/2008. The medicines in 281 lawsuits were examined for their respective indications, classified according to their presence in publicly-funded lists, market approval by ANVISA, compliance with national clinical guidelines, existence of alternative therapies in lists and support of indication by scientific evidence. Six different categories were described, which are deemed useful to managers and the Judiciary in decision-making. The support of evidence is of utmost importance for medicines that are not included in public funding lists and also for those with no available therapeutic alternatives.
publishDate 2013
dc.date.none.fl_str_mv 2013-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-311X2013001300014
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-311X2013001300014
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/0102-311X00161812
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Escola Nacional de Saúde Pública Sergio Arouca, Fundação Oswaldo Cruz
publisher.none.fl_str_mv Escola Nacional de Saúde Pública Sergio Arouca, Fundação Oswaldo Cruz
dc.source.none.fl_str_mv Cadernos de Saúde Pública v.29 suppl.1 2013
reponame:Cadernos de Saúde Pública
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Cadernos de Saúde Pública
collection Cadernos de Saúde Pública
repository.name.fl_str_mv Cadernos de Saúde Pública - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv cadernos@ensp.fiocruz.br||cadernos@ensp.fiocruz.br
_version_ 1754115734229745664

Registros relacionados